Literature DB >> 8699122

The inflammatory macrophage response to MCMV in mice with a retroviral immunodeficiency syndrome (MAIDS).

R J Allcock1, C D Peacock, P Price.   

Abstract

We have shown that normal C57BL/6J mice are moderately resistant to infection with murine cytomegalovirus (MCMV) and that this resistance is impaired by prior infection with LP-BM5 MuLV, which causes a disease (MAIDS) similar to early HIV-induced disease. This study investigates macrophage function in MAIDS+ mice challenged with MCMV. MAIDS reduces the influx of cells into the peritoneal cavity seen in normal C57BL/6J mice 6 days after MCMV infection. The infiltrates contained cells that resembled activated macrophages, as they took up colloidal gold, expressed the macrophage marker Mac-1, had high levels of acid phosphatase activity, and were lymphocytostatic when co-cultured with activated T cells. MAIDS+ mice had a higher percentage of cells able to take up colloidal gold and higher acid phosphatase activity per cell. The cells were also more lymphocytostatic and produced higher levels of interleukin-1 and tumor necrosis factor-alpha on days 4 and 6 after MCMV infection. Hence, MAIDS enhances baseline and induced macrophage activity, but depresses infiltration into the site of inflammation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699122     DOI: 10.1002/jlb.60.1.44

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  3 in total

1.  The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.

Authors:  S T Yerkovich; S D Olver; J C Lenzo; C D Peacock; P Price
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  Effect of a retroviral immunodeficiency syndrome on murine cytomegalovirus-induced hepatitis.

Authors:  C D Peacock; S D Olver; P Price
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

3.  An interleukin-1 beta-encoding retrovirus exhibits enhanced replication in vivo.

Authors:  Edward P Browne
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.